Providing a diverse range of perspectives from bullish to bearish, 14 analysts have published ratings on NICE NICE in the last three months.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 5 | 9 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 4 | 5 | 0 | 0 | 0 |
| 2M Ago | 0 | 3 | 0 | 0 | 0 |
| 3M Ago | 0 | 1 | 0 | 0 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $315.43, a high estimate of $343.00, and a low estimate of $270.00. Observing a 21.47% increase, the current average has risen from the previous average price target of $259.67.
Exploring Analyst Ratings: An In-Depth Overview
The analysis of recent analyst actions sheds light on the perception of NICE by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Gil Luria | DA Davidson | Raises | Buy | $300.00 | $250.00 |
| Gil Luria | DA Davidson | Raises | Buy | $300.00 | $250.00 |
| Patrick Walravens | JMP Securities | Maintains | Market Outperform | $343.00 | - |
| Tyler Radke | Citigroup | Raises | Buy | $335.00 | $334.00 |
| Rishi Jaluria | RBC Capital | Raises | Outperform | $285.00 | $238.00 |
| Siti Panigrahi | Mizuho | Raises | Buy | $300.00 | $244.00 |
| Tavy Rosner | Barclays | Raises | Overweight | $320.00 | $283.00 |
| Daniel Ives | Wedbush | Raises | Outperform | $270.00 | $230.00 |
| Timothy Horan | Oppenheimer | Raises | Outperform | $300.00 | $225.00 |
| Tyler Radke | Citigroup | Raises | Buy | $334.00 | $283.00 |
| Patrick Walravens | JMP Securities | Maintains | Market Outperform | $343.00 | - |
| Michael Latimore | Northland Capital Markets | Announces | Outperform | $300.00 | - |
| Patrick Walravens | JMP Securities | Maintains | Market Outperform | $343.00 | - |
| Patrick Walravens | JMP Securities | Maintains | Market Outperform | $343.00 | - |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to NICE. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of NICE compared to the broader market.
- Price Targets: Analysts predict movements in price targets, offering estimates for NICE's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.
To gain a panoramic view of NICE's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on NICE analyst ratings.
Unveiling the Story Behind NICE
Nice is an enterprise software company that serves the customer engagement and financial crime and compliance markets. The company provides data analytics-based solutions through both a cloud platform and on-premises infrastructure. Within customer engagement, Nice's CXone platform delivers solutions focused on contact center software and workforce engagement management, or WEM. Contact center offerings include solutions for digital self-service, customer journey and experience optimization, and compliance. WEM products optimize call center efficiency, leveraging data and AI analytics for call volume forecasting and agent scheduling. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money laundering, and compliance solutions.
NICE's Financial Performance
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: NICE displayed positive results in 3 months. As of 31 December, 2023, the company achieved a solid revenue growth rate of approximately 3.63%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 13.1%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): NICE's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 2.49%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): NICE's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 1.63%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: NICE's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.23.
Analyst Ratings: Simplified
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
